There are many people that suffer from eczema and the treatment they need for this condition, eczema is a special one. Nowadays many efforts are being done do discover eczema treatments or to cure other skin conditions, because the number of people that suffer from skin problems, like eczema is getting bigger by the second.
Some scientists have also discovered the gene which is responsible for dry skin, which immediately leads to an eczema. The same gene that leads to eczema is also responsible for asthma. This particular gene produces a protein called fillagrin, which helps the skin like a barrier. without it, your skin gets very dry and eczema develops. The people who are responsible for this discovery, that may lead to finding a better eczema cure, hope to do just that, instead of only treating the eczema symptoms. There is a desperate serch for an eczema treatment, because at this point the only available eczema treatment are with ointments or creams. Anti inflammatory drugs can also be taken in cases of an eczema. Those treatments for eczema only lower the symptoms and make you feel better. What scientists want is to find a cure for eczema, instead of trying only to treat the eczema symptoms.
Fillagrin, this protein such crucial in stopping eczema, has the role to keep viruses and bacteria out of your skin, while it also keeps water in, thus preventing the drying of your skin and the forming of an eczema. Descovering this gene is probably one of the crucial moments in eczema treatment and asthma. This simple discovery can be a new, fresh beginning in skin problems, like eczema. Before this discovery was made, doctor, patients where just throwing water on a burning building.
People who were suffering from eczema, and even chronic eczema did not have any choice but to go to the hospital almost every day and get bandages. However, now that this discovery was made, thinks might change for people with eczema. They do not know how long it will take them to find the proper treatment for eczema, in light of this discovery. One thing is for sure, thought, a new, better eczema treatment will be found.
More studies have shown that almost ten percent of all people that live in Europe have a genetical mutation that turns off the protein that helps us in not developing an eczema.
Metastatic disease requires treatment of the original tumor site if applicable. Some primary brain tumors respond to certain forms of therapy better than others. Metastatic brain tumors are classified depending on the exact site of the tumor within the brain, type of tissue involved, original location of the tumor, and other factors.
Infrequently, a tumor can spread to the brain, yet the original site or location of the tumor is unknown. Metastatic brain tumors occur in about one-fourth of all cancers that metastasize (spread through the body). They are much more common than primary brain tumors .
Astrocytomas may also start here. Astrocytomas are generally subdivided into high-grade or low-grade tumors. High-grade astrocytomas are the most malignant of all brain tumors.
Ependymomas make up about 8-10% of pediatric brain tumors. The tumors are located in tiny passageways (ventricles) in the brain, and block the flow of cerebrospinal fluid (CSF). Ependymomas can be slow growing, compared to other brain tumors, but may recur after treatment is completed. Recurrence of ependymomas results in a more invasive tumor with more resistance to treatment.
Contrast dye is intravenously administered and the scanner starts taking a rapid succession of images this traces the path of blood flow into the brain and brain tumor. MRI Angiography (MRA) uses MRI scans to outline blood vessels in the brain by following blood flow. Angiography is used to plan the surgical removal of a tumor suspected to have a large blood supply or one located in a part of the brain with?dense blood vessels.
Contrast agent uptake, sometimes in characteristic patterns, can be demonstrated on either CT or MRI-scans in most malignant primary and metastatic brain tumors. This is due to the fact that these tumors disrupt the normal functioning of the blood-brain barrier and lead to an increase in its permeability.
Now neurological progression can be effectively controlled in most patients harboring a few intracranial metastases with aggressive focal treatment (surgery or radiosurgery) in combination with WBR.
WBR can be given immediately following focal treatment or at the time of recurrence. Control can be extended by frequent MR surveillance of the brain and radiosurgical treatment of new metastases months or years later. With control of intracranial disease, advances in cancer therapy will prolong survival, since most patients now succumb later to systemic, rather than intracranial disease.
Aggressive, focal treatment is only beneficial in patients with controlled or no systemic disease and independent health (Karnofsky Performance Score (KPS) 70). Age is also a determinant of outcome, with better outcomes in individuals less than 60 years old.
Both Groshan Fabiola & Alisha Dhamani are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Groshan Fabiola has sinced written about articles on various topics from Woman Menopause, Medical Condition and Health. For more resources about or even about. Groshan Fabiola's top article generates over 6120000 views. to your Favourites.
Alisha Dhamani has sinced written about articles on various topics from Web Development, Careers and Job Hunting and Health. Jigfo.com is a global platform for sharing and learning knowledge. For more information on this article topics visit:. Alisha Dhamani's top article generates over 18100 views. to your Favourites.